[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100573664":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":7,"centralContacts":13,"locations":19,"responsibleParty":38,"collaborators":7,"id":40,"slug":41,"hasResults":42,"nctId":43,"briefTitle":44,"officialTitle":44,"acronym":7,"eligibilityCriteria":45,"healthyVolunteers":42,"sex":46,"minAge":47,"maxAge":7,"enrollmentInfo":48,"targetDuration":7,"studyType":51,"phases":7,"briefSummary":52,"conditions":53,"keywords":55,"overallStatus":22,"whyStopped":7,"lastUpdateSubmitDate":57,"lastUpdatePostDateStruct":58,"startDateStruct":61,"completionDateStruct":63,"leadSponsor":65,"locationsCount":66},{"fullName":5,"class":6},"Radiometer Medical ApS","INDUSTRY",null,[9],{"type":10,"name":11,"description":12,"armGroupLabels":7,"otherNames":7},"DIAGNOSTIC_TEST","D-dimer test","Blood sample collection for D-dimer testing",[14],{"name":15,"role":16,"phone":17,"phoneExt":7,"email":18},"Helle Toftegaard Petersen","CONTACT","+45 29259390","helle.toftegaard@radiometer.dk",[20],{"facility":21,"status":22,"city":23,"state":7,"zip":24,"country":25,"countryCode":26,"cosmosGeoPoint":27,"geoPoint":32,"contacts":33},"Viborg Regional Hospital","RECRUITING","Viborg","8800","Denmark","DK",{"type":28,"coordinates":29},"Point",[30,31],9.40201,56.45319,{"lat":31,"lon":30},[34],{"name":35,"role":16,"phone":36,"phoneExt":7,"email":37},"Jurgita Janukonyté, MD, PhD","+45 78 44 34 12","jurgjanu@rm.dk",{"type":39,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100573664","aqt90-flex-d-dimer-clinical-sensitivity-and-specificity-100573664",false,"NCT06749223","AQT90 FLEX D-dimer Clinical Sensitivity and Specificity","Inclusion Criteria:\n\n* Subject is 18 years of age and older\n* Subject, who presents with signs and symptoms of VTE and had low or moderate pre-test probability of DVT or PE assessed by Well's score\n* Subject must be able to understand information given, and be willing and able to voluntarily give their consent to participate in this study\n\nExclusion Criteria:\n\n* Subject, who is pregnant\n* Subject, who has received fibrinolytic therapy within the previous seven days\n* Subject, who has received treatment with anticoagulants (unfractionated heparin, LMWH, VKA (vitamin K-antagonists), DOACs (direct oral anticoagulants) within the previous seven days\n* Subject, who has had trauma or surgery within the previous four weeks\n* Subject with malignancy\n* Subject with disseminated intravascular coagulation (DIC)\n* Subject, who has an invalid written informed consent or has withdrawn consent","ALL","18 Years",{"count":49,"type":50},600,"ESTIMATED","OBSERVATIONAL","The goal of this study is evaluate the clinical performance of the AQT90 FLEX D-dimer Test as an aid in the diagnosis of Venous Thromboembolism.",[54],"VTE (Venous Thromboembolism)",[56],"D-dimer","2025-02-13",{"date":59,"type":60},"2025-02-17","ACTUAL",{"date":62,"type":60},"2022-04-04",{"date":64,"type":50},"2025-06-30",{"name":5,"class":6},1]